These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6323690)

  • 1. Characterization of the alpha adrenoceptor-mediated effects and antihypertensive activity of ICI 106270: comparison with clonidine.
    Ruffolo RR; Yaden EL; Timmermans PB; van Zwieten PA; Hynes MD
    J Pharmacol Exp Ther; 1984 Apr; 229(1):58-66. PubMed ID: 6323690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new centrally acting antihypertensive (ICI 106270) which separates antihypertensive effects from sedation.
    Clough DP; Hatton R; Pettinger SJ
    Arzneimittelforschung; 1981; 31(10):1698-703. PubMed ID: 7198445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacology.
    Ryan MJ; Bjork FA; Cohen DM; Coughenour LL; Major TC; Mathias NP; Mertz TE; Olszewski BJ; Singer RM; Evans DB
    J Pharmacol Exp Ther; 1986 Aug; 238(2):473-9. PubMed ID: 2874210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific binding of 3H-guanfacine to alpha 2-adrenoceptors in rat brain. Comparison with 3H-clonidine.
    Dausse JP; Cardot A; Meyer P
    J Pharmacol; 1983; 14(1):35-46. PubMed ID: 6300560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique presynaptic alpha 2-receptor selectivity and specificity of the antihypertensive agent moxonidine.
    Armah BI
    Arzneimittelforschung; 1988 Oct; 38(10):1435-42. PubMed ID: 2848533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).
    Honda K; Takenaka T; Miyata-Osawa A; Terai M
    J Pharmacol Exp Ther; 1986 Mar; 236(3):776-83. PubMed ID: 2869143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alpha 1- and alpha 2-adrenoceptor selectivity of drugs with potential effects on blood pressure--a radioligand-binding study.
    Offermeier J; van Rooyen JM; Rossouw J
    S Afr Med J; 1986 Feb; 69(4):234-6. PubMed ID: 2869590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotensive and sedative effects of alpha-adrenoceptor agonists: relationship to alpha 1- and alpha 2-adrenoceptor potency.
    Clough DP; Hatton R
    Br J Pharmacol; 1981 Jul; 73(3):595-604. PubMed ID: 6113864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of radioreceptor assays in determining the mechanism of action of hypotensive alpha-adrenergic compounds].
    Dausse JP; Guicheney P; Meyer P
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():45-50. PubMed ID: 6271088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    Seidel WF; Maze M; Dement WC; Edgar DM
    J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Centrally acting sympathetic inhibitors for therapy of patients with hypertension].
    Kawasaki H
    Nihon Rinsho; 1997 Aug; 55(8):2081-5. PubMed ID: 9284427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of [3H]clonidine binding to rat brain alpha-adrenoceptors by imidazolidines. Correlation of binding potency and hypotensive activity.
    Bechtel WD; Mierau J; Timmermans PB
    Arzneimittelforschung; 1985; 35(1A):428-31. PubMed ID: 2985095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats.
    El-Mas MM; Omar AG; Helmy MM; Mohy El-Din MM
    Brain Res; 2009 Jan; 1248():96-106. PubMed ID: 19028461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonic vocalization production of preweanling rats: effects of central and peripheral administration of alpha2-adrenoceptor agonists.
    Krall CM; Andicochea CT; McDougall SA
    Eur J Pharmacol; 2005 Jul; 517(3):200-7. PubMed ID: 15985263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between activity and structure in derivatives of clonidine.
    Hoefke W; Kobinger W; Walland A
    Arzneimittelforschung; 1975 May; 25(5):786-93. PubMed ID: 1242325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats.
    Hohage H; Schlatter E; Greven J
    Clin Nephrol; 1997 May; 47(5):316-24. PubMed ID: 9181279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.